Product Description: GSK269962A (GSK 269962) is a potent ROCK inhibitor with IC50s of 1.6 and 4 nM for recombinant human ROCK1 and ROCK2 respectively. GSK269962A has anti-inflammatory and vasodilatory activities[1].
Applications: COVID-19-anti-virus
Formula: C29H30N8O5
References: [1]Doe C, et al. Novel Rho kinase inhibitors with anti-inflammatory and vasodilatory activities. J Pharmacol Exp Ther. 2007 Jan;320(1):89-98.
CAS Number: 850664-21-0
Molecular Weight: 570.60
Compound Purity: 99.83
Research Area: Inflammation/Immunology; Cardiovascular Disease